IGX Solutions

Pharmaceuticals and biotechnology

In a GxP environment, aligning what a procedure says with the records of what happens on the line is central to compliance. IGX360 Insights gives pharmaceutical and biotechnology organisations one trusted, evidenced view of their processes, so quality and regulatory teams work from the same evidence an inspector will ask to see.

10 ways to get ahead in Pharmaceuticals and biotechnology

Establish how the work runs today

  • Process discovery
  • Current-state mapping
  • Operating baseline

In your words: “We do not know how work really happens”

A governed, connected view of how work runs gives every team the same starting point. It replaces individual descriptions with one baseline that can be queried, owned and kept current.

Know which of your process knowledge you can stand behind

  • Process repository
  • Single source of truth
  • Knowledge governance

In your words: “Our process knowledge is fragmented and untrusted”

Content held across Visio, SharePoint, SOPs and spreadsheets works as one source once versions, owners and dates are visible. Then people know which version is authoritative and who to ask.

Prove your compliance with evidence

  • Continuous compliance
  • Control assurance
  • Audit readiness

In your words: “We think we are compliant but cannot prove it”

Traceability from obligation through process, owner, system, control and retained evidence lets you show how a duty is met, whenever you are asked.

Bring your documented process and daily work together

  • Design-reality gap
  • Process validation
  • Execution alignment

In your words: “Our documented process is not how the work actually gets done”

When the process model and daily execution are connected, the model stays useful and governance reflects real work. Approved workarounds become part of the design.

Turn execution evidence into learning

  • Learning from execution
  • Execution evidence
  • Governed learning

In your words: “Our systems tell us what happened, but not why the process failed or what to change”

When execution evidence is retained and connected, the organisation can see not just what happened but why, and what to change.

Connect risks, controls, processes and obligations

  • Risk-control traceability
  • Obligation mapping
  • Connected assurance

In your words: “Risks, controls, processes and obligations are disconnected”

A connected process-centric risk model shows which processes create each risk, which controls operate within them and where coverage can be strengthened.

Turn regulatory change into process change

  • Regulatory change impact
  • Obligation-to-process mapping
  • Compliance agility

In your words: “When regulations change, we cannot quickly identify every process, control, system and role affected”

Connected impact analysis identifies affected processes, systems, controls, roles and suppliers consistently, so implementation starts from a complete list.

Embed and evidence EMA and EU medicines duties

  • GxP compliance
  • EMA medicines regulation
  • Lifecycle traceability

In your words: “EMA and EU medicines requirements are difficult to embed and evidence”

Connecting procedures, roles, systems, controls and inspection evidence across the medicinal-product lifecycle keeps them aligned as things change.

Make governance shape what people do

  • Governance execution
  • Policy-to-practice
  • Control observability

In your words: “Our governance says what should happen, but does not reliably control what people actually do”

Governance that changes tasks, decision thresholds, approvals, escalation and evidence capture is governance you can rely on in operation.

Make your safety-management system shape daily work

  • Safety management system
  • Operational safety assurance
  • SMS embedding

In your words: “Safety-management systems do not reliably shape daily work”

When mitigations, competence, occurrence reporting and assurance are embedded in workflow, the safety-management system shapes daily work.